Abstract:A series of novel 2-aryl-benzimidazole derivatives of dehydroabietic acid were synthesized and characterized by IR, 1H NMR, 13C NMR, MS and elemental analyses. All the target compounds were evaluated for their in vitro cytotoxic activity against SMMC-7721, MDA-MB-231, HeLa and CT-26 cancer cell lines and the normal hepatocyte cell line QSG-7701 through MTT assays. Among them, compound 6j displayed the most potent cytotoxic activity with IC50 values of 0.08 ± 0.01, 0.19 ± 0.04, 0.23 ± 0.05 and 0.42 ± 0.07 μM, respectively, and substantially reduced cytotoxicity against QSG-7701 cells (5.82 ± 0.38 μM). The treatment of SMMC-7721 cells with compound 6j led to considerable inhibition of cell migration ability. The influence of compound 6j on cell cycle distribution was assessed on SMMC-7721 cells, exhibiting a cell cycle arrest at the G2/M phase. Moreover, tubulin polymerization assays and immunofluorescence assays elucidated that compound 6j could significantly inhibit tubulin polymerization and disrupt the intracellular microtubule network. A molecular docking study provided insight into the binding mode of compound 6j in the colchicine site of tubulin. In addition, compound 6j was found to induce apoptosis of SMMC-7721 cells, an increase of intracellular ROS level and a loss of mitochondrial membrane potential in a dose-dependent manner. These findings provided new molecular scaffolds for the further development of novel antitumor agents targeting tubulin polymerization.

Two New Cytotoxic Maytansinoids Targeting Tubulin from Trewia nudiflora

Novel Triterpenoids from Microtropis Triflora with Antitumor Activities.

Streptonaphthyridine A, a New Naphthyridine Analogue with Antiproliferative Activity Against Human Glioma Cells from Mariana Trench-Associated Actinomycete Streptomyces Sp. SY2111

Cytotoxic Activity of Trewiasine in 4 Human Cancer Cell Lines and 5 Murine Tumors.

Synthesis, biological evaluation, and molecular docking studies of cinnamic acyl 1,3,4-thiadiazole amide derivatives as novel antitubulin agents.

Synthesis, Biological Evaluation, and Molecular Docking Studies of Novel 1-Benzene Acyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Potential Tubulin Polymerization Inhibitors

Discovery of (2-(pyrrolidin-1-yl)thieno[3,2- d ]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone as a novel potent tubulin depolymerizing and vascular disrupting agent

Synthesis, Biological Evaluation, and Molecular Docking Studies of 2,6-Dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime Derivatives As Novel Antitubulin Agents.

Diterpenoids from Torreya grandis and their cytotoxic activities

Determination of maytansinoids in Trewia nudiflora using QuEChERS extraction combined with HPLC

Synthesis, Biological Evaluation and Molecular Modeling of 1,3,4-Thiadiazol-2-amide Derivatives As Novel Antitubulin Agents.

Trichothecene macrolides from the endophytic fungus Paramyrothecium roridum and their cytotoxic activity

Synthesis, Biological Evaluation, and Molecular Modeling of Cinnamic Acyl Sulfonamide Derivatives As Novel Antitubulin Agents

Synthesis, Molecular Modeling and Biological Evaluation of Dithiocarbamates As Novel Antitubulin Agents

Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors

New Cytochalasins from Medicinal Macrofungus Crodyceps Taii and Their Inhibitory Activities Against Human Cancer Cells.

Tirucallane-type Triterpenoids from the Fruits of Phellodendron Chinense Schneid and Their Cytotoxic Activities.

Design, Synthesis and Biological Evaluation of Novel Diarylpyridine Derivatives As Tubulin Polymerisation Inhibitors

Discovery of a Chiral Fluorinated Azetidin-2-one As a Tubulin Polymerisation Inhibitor with Potent Antitumour Efficacy

Discovery and Molecular Modeling of Novel 1-Indolyl Acetate--5-nitroimidazole Targeting Tubulin Polymerization As Antiproliferative Agents.

Synthesis, Molecular Docking and Biological Evaluation of 1-Phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole Derivatives As Novel Potential Tubulin Assembling Inhibitors